Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
Completed · Not applicable
Conditions studied: Dry Eye, Dry Eye Syndromes
In brief
This study characterizes acute dry eye symptom control, assessed during exposure to a Controlled Adverse Environment, following use of the TrueTear for 45 days.
Key facts
- Study ID
- NCT03097614
- Run by
- Oculeve, Inc.
- People needed
- 57
- Starts
- 2017-03-31
- Expected to finish
- 2017-06-26
- Last updated by the study team
- 2018-10-18
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have used and/or desired to use an artificial tear substitute for dry eye symptoms within 6 months prior to the Screening Visit
- Normal lid/lash anatomy, blinking function and closure as determined by the Investigator
- Literate, able to speak English, and able to complete questionnaires independently
You may not qualify if…
- Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the Investigator, may lead to risk of clinically significant increased bleeding
- Nasal or sinus surgery (including history of application of nasal cautery) or significant trauma to these areas
- Contact lens use within 7 days prior to the Screening Visit or anticipate the use of contact lenses at any time during the study
- Corneal transplant in either or both eyes
- Cardiac demand pacemaker, implanted defibrillator, or other active implanted metallic or active implanted electronic device in the head
- A woman who is pregnant, nursing an infant, or planning a pregnancy during the duration of the study
- Currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days prior to the Screening Visit
Where it is running
- Andover Eye Associates — Andover, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.